S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Urgent Warning (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
The "King Of Quants" sees 10X potential... (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
BREAKING: Tiny biotech successfully treats blindness (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Urgent Warning (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
The "King Of Quants" sees 10X potential... (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
BREAKING: Tiny biotech successfully treats blindness (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Urgent Warning (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
The "King Of Quants" sees 10X potential... (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
BREAKING: Tiny biotech successfully treats blindness (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Urgent Warning (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
The "King Of Quants" sees 10X potential... (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
BREAKING: Tiny biotech successfully treats blindness (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
NYSE:MCC

PhenixFIN - MCC Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$36.26
$36.26
50-Day Range
$28.31
$35.06
52-Week Range
$7.00
$45.20
Volume
168 shs
Average Volume
13,927 shs
Market Capitalization
$98.78 million
P/E Ratio
N/A
Dividend Yield
5.79%
Price Target
N/A

MCC stock logo

About PhenixFIN (NYSE:MCC) Stock

Medley Capital Corporation is a business development company. The fund seeks to invest in privately negotiated debt and equity securities of small and middle market companies. It primarily invests in the following sectors: business services; buildings and real estate; automobile; oil and gas; aerospace and defense; home and office furnishings, housewares, and durable consumer products; healthcare, education and childcare; personal, food, and miscellaneous services; retail stores, diversified or conglomerate manufacturing; telecommunications; mining, steel, iron, and non-precious metals; leisure, amusement, motion pictures, and entertainment; chemicals, plastics, and rubber; finance; personal and nondurable consumer products (manufacturing only); beverage, food, and tobacco; containers, packaging, and glass; structure finance securities; machinery (non-agriculture, non-construction, non-electric); diversified or conglomerate service; restaurant and franchise; electronics; and cargo transport. The fund seeks to invest in companies located in North America. The fund targets private debt transactions in companies with enterprise values or asset values between $25 million and $250 million. The fund seeks to invest in companies with debt investment values between $10 million and $50 million. It exits its investments between three years and seven years; it holds most of its investments to maturity or repayment, but may realize or sell some investments earlier. The fund may take a board seat on its investee companies and can also offer managerial assistance to certain portfolio companies. It structures its investments as first lien senior secured loans, second lien senior secured loans, senior secured notes, senior subordinated notes, subordinate notes, unitranche loans, and seeks warrants or other equity participation. The fund may co-invest in privately negotiated transactions under certain conditions.

Receive MCC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PhenixFIN and its competitors with MarketBeat's FREE daily newsletter.

MCC Stock News Headlines

"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast
Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
Bull Of The Day: Jabil (JBL) - Yahoo Finance
See More Headlines
Receive MCC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PhenixFIN and its competitors with MarketBeat's FREE daily newsletter.

MCC Company Calendar

Last Earnings
12/10/2020
Today
3/27/2023

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
Asset Management & Custody Banks
Sector
Finance
CUSIP
58503F10
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-96,570,000.00
Net Margins
-391.54%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$46.30 million
Book Value
$79.46 per share

Miscellaneous

Free Float
N/A
Market Cap
$98.78 million
Optionable
Optionable
Beta
1.80

Key Executives

  • Mr. Brook Taube CFA (Age 51)
    Chairman, Pres & CEO
  • Mr. Richard Thomas Allorto Jr. (Age 49)
    CPA, CPA, CFO & Sec.
  • Mr. Dean Christopher Crowe (Age 58)
    Managing Director and Head of Investing
  • Mr. Elio Espinal
    VP and IT Mang.
  • Mr. Samuel Anderson
    SMD, Head of Capital Markets & Risk Management
  • Mr. John Donnan Fredericks (Age 56)
    Chief Compliance Officer
  • Mr. Nathan Bryce
    Assistant Gen. Counsel
  • Mr. Jubal Raffety
    Managing Director and Head of Talent Devel.
  • Mr. Brian Dohmen
    Sr. MD and Head of Direct Lending & Origination
  • Mr. Kevin W. Hah CPA
    Managing Director and Controller













MCC Stock - Frequently Asked Questions

How were PhenixFIN's earnings last quarter?

PhenixFIN Co. (NYSE:MCC) released its earnings results on Thursday, December, 10th. The investment management company reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.18) by $0.14. PhenixFIN had a negative net margin of 391.54% and a negative trailing twelve-month return on equity of 8.08%.

Is PhenixFIN a good dividend stock?

PhenixFIN (NYSE:MCC) pays an annual dividend of $2.10 per share and currently has a dividend yield of 7.42%. MCC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for MCC.

When did PhenixFIN's stock split?

PhenixFIN shares reverse split on the morning of Monday, July 27th 2020. The 1-20 reverse split was announced on Monday, July 13th 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 24th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of PhenixFIN own?
What is PhenixFIN's stock symbol?

PhenixFIN trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCC."

What is PhenixFIN's stock price today?

One share of MCC stock can currently be purchased for approximately $36.26.

How much money does PhenixFIN make?

PhenixFIN (NYSE:MCC) has a market capitalization of $98.78 million and generates $46.30 million in revenue each year. The investment management company earns $-96,570,000.00 in net income (profit) each year or ($0.68) on an earnings per share basis.

How can I contact PhenixFIN?

PhenixFIN's mailing address is 280 PARK AVENUE 6TH FLOOR EAST, NEW YORK NY, 10017. The official website for the company is www.medleycapitalcorp.com. The investment management company can be reached via phone at 212-759-0777 or via email at sam.anderson@mdly.com.

This page (NYSE:MCC) was last updated on 3/28/2023 by MarketBeat.com Staff